Objective
OrganoVIR (Organoids for Virus Research) will train young researchers (ESRs) in the field of organoids and virology. Human viral infection studies lack suitable experimental models as animal models or conventional 2-dimensional (2D) cell cultures do not translate to human infection. OrganoVIR makes use of the breakthrough in the culturing of primary human cells into 3D cultures (organoids). Within this ETN programme, organoids will be used for the first time to study human viral infections in their natural environment.
OrganoVIR includes leading partners in virology and organoid technology covering 7 academic institutes, 3 life science companies, 1 organoid technology private company, 2 non-profit organisations, a national public health institute and a business school originating from 8 countries.
The aim is to introduce and establish human organoids as superior models for viral pathogenesis studies and antiviral testing, thus replacing animal models and reducing animal use. OrganoVIR provides a full package ETN programme for ESRs to learn the science of innovative 3D culture systems for virus research as well as financial, commercial, ethical, communicative, policy and dissemination aspects for optimal valorization. The projects are intensified by significant secondments at commercial, governmental and non-profit partner institutes.
OrganoVIR provides:
- High-ranked scientific and technical training in an interdisciplinary, intersectoral and international top research project
- Training in transferrable managerial skills, including a pre-MBA
- Implementation of innovative organoid technology for viral pathogenesis studies and antiviral development
- Innovation in organoid technology by co-culture design and high throughput screening.
OrganoVIR combines frontier research with an innovative training programme in a complementary network, certifying high impact scientists.
Fields of science
Programme(s)
Funding Scheme
MSCA-ITN-ETN - European Training NetworksCoordinator
1105AZ Amsterdam
Netherlands
See on map
Participants (9)
3000 Leuven
See on map
31-007 Krakow
See on map
2800 Kgs Lyngby
See on map
CB25 9TL Cambridge
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
3584 CS Utrecht
See on map
2333 CR Leiden
See on map
1211 Geneve
See on map
1012WX Amsterdam
See on map
63000 Clermont Ferrand
See on map
Partners (5)
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
21205 Baltimore, Md,
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
2517 ES Den Haag
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
3721 MA Bilthoven
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
1228 Plan Les Ouates
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
1011 JV Amsterdam
See on map